The U.S. Food and Drug Administration (FDA) has approved Revuforj (revumenib), which is a menin inhibitor, for the treatment ...

To understand treatment patterns and preferences, a series of expert-led Case-Based Roundtable events were conducted over the ...

First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A ...

The approval is based on data from a Phase III trial evaluating patients who had received two or more previous treatments.

The latest update is out from Syndax Pharmaceuticals ( (SNDX) ).

Patients enrolled had NET liver metastases of any grade or origin that were progressive, symptomatic, or represented a high ...

London: GSK plc has received approval from the US Food and Drug Administration (FDA) for Blenrep (belantamab mafodotin-blmf) ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

BLENREP is indicated in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of ...

Two decades ago, manufacturers launched patient support services to counter a distorted pharmaceutical supply chain - one designed for intermediaries, not patients, that shifts complexity and cost ...

GSK’s Blenrep receives US FDA approval to treat relapsed/refractory multiple myeloma: London, UK Saturday, October 25, 2025, 11:00 Hrs [IST] GSK plc announced the US Food and Dr ...

A prostate biopsy involves removing prostate tissue to test for cancer. Learn about types, procedure, risks, and follow-up ...